PacBio (NASDAQ: PACB), developer of the world's most advanced sequencing technologies, today announced CiFi, a new community-developed method that enables chromosome-scale, haplotype-resolved genome ...
Zacks Investment Research on MSN
Here's why you should add PacBio stock to your portfolio
Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, has been gaining from its continued product ...
PacBio CEO Christian Henry speaks on day one of the in-person meeting of American Society of Human Genetics, the first in-person since 2019 Menlo Park-based Pacific Biosciences (PacBio) kicked off the ...
StockStory.org on MSN
PacBio (PACB) stock is up, what you need to know
What Happened? Shares of genomics company Pacific Biosciences of California (NASDAQ:PACB) jumped 2.9% in the morning session ...
Pacific Biosciences of California (PACB) concluded the recent trading session at $2.13, signifying a +2.4% move from its prior day's close.
(Reuters) - Gene-sequencing company Pacific BioSciences of California Inc on Tuesday announced the launch of a new, more affordable, higher-throughput "long-read" sequencer as well as customer testing ...
StockStory.org on MSN
Stocks making big moves this week: PacBio, Crocs, FuelCell Energy, AMC Entertainment, and ON24
Genomics company Pacific Biosciences of California (NASDAQ:PACB) rose by 6.1% on Wednesday after Cathie Wood's investment ...
MENLO PARK, Calif., Dec. 30, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be ...
Pacific Biosciences raised the curtain on two DNA sequencers: its first short-read device, designed to offer new competition to the industry giant Illumina, as well as a machine poised to be an ...
PacBio's financials for 2023 show significant growth, with revenue more than doubling in Q4 and a 56% increase in annual revenue compared to the previous year. The company's product innovations, such ...
Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, has been gaining from its continued focus on research and development. The optimism, led by decent second-quarter 2024 earnings ...
(RTTNews) - PacBio (PACB), a developer of highly accurate sequencing solutions, is slated to participate in several upcoming investor conferences this month, underscoring its visibility within the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback